IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the appointment of Gunnar Olsson as CEO has been extended.
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the appointment of Gunnar Olsson as CEO has been extended.